The new Viral Hepatitis Clinic offers patients the latest therapies and follows the treatment model in HIV care pioneered by the 1917 Clinic.
Mirjam-Colete Kempf, Ph.D., M.P.H., and Michael Saag, M.D., received a $3 million, five-year award to join the Women’s Interagency HIV study.
Of the 27 antiretroviral drugs now approved for AIDS, seven were tested first in patients at the 1917 Clinic in Phase 1 clinical trials.
The School of Medicine rose to No. 10 in the country in primary care, 34th in research.